INS and Alzheimer disease: Importantly, clinical trials showed that selenium supplementation regimens were well tolerated, improved insulin homeostasis, and slowed disease progression in AD patients (Malpas et al., 2016; Tamtaji et al., 2019; Vivash et al., 2021).